Latin America Antisense And Rnai Therapeutics Market Size & Outlook
The antisense and rnai therapeutics market in Latin America is expected to reach a projected revenue of US$ 230.2 million by 2030. A compound annual growth rate of 16.4% is expected of Latin America antisense and rnai therapeutics market from 2024 to 2030.
- Biotechnology
- RNA analysis
- Antisense And RNAi Therapeutics Market Outlook
- RNA analysis
Revenue, 2023 (US$M)
$80.1
Forecast, 2030 (US$M)
$230.2
CAGR, 2024 - 2030
16.4%
Report Coverage
Latin America
Latin America Antisense And Rnai Therapeutics Market, 2018-2030 (US$M)
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the antisense and rnai therapeutics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Latin America antisense and rnai therapeutics market highlights
- The Latin America antisense and rnai therapeutics market generated a revenue of USD 80.1 million in 2023.
- The market is expected to grow at a CAGR of 16.4% from 2024 to 2030.
- In terms of segment, rna interference was the largest revenue generating technology in 2023.
- RNA Interference is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 80.1 million |
| Market revenue in 2030 | USD 230.2 million |
| Growth rate | 16.4% (CAGR from 2024 to 2030) |
| Largest segment | Rna interference |
| Fastest growing segment | RNA Interference |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | RNA Interference, Antisense RNA |
| Key market players worldwide | GSK PLC, Sanofi SA, Alnylam Pharmaceuticals Inc, Arbutus Biopharma Corp, Benitec Biopharma Inc, Silence Therapeutics PLC, Ionis Pharmaceuticals Inc, Sarepta Therapeutics Inc, Percheron Therapeutics Ltd |
Other key industry trends
- In terms of revenue, Latin America region accounted for 1.8% of the global antisense and rnai therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 9,465.2 million by 2030.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antisense And RNAi Therapeutics Market Scope
Antisense And RNAi Therapeutics Market segmentation & scope
Ocular
Cancer
Skin Diseases
Infectious Diseases
Other Delivery Methods
Antisense And RNAi Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Ionis Pharmaceuticals Inc | View profile | 927 | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 | www.ionispharma.com |
| Alnylam Pharmaceuticals Inc | View profile | 2,100 | 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, United States, 02142 | www.alnylam.com |
| Arbutus Biopharma Corp | View profile | 73 | 701 Veterans Circle, Warminster, PA, United States, 18974 | www.arbutusbio.com |
| Benitec Biopharma Inc | View profile | 16 | 3940 Trust Way, Hayward, CA, United States, 94545 | www.benitec.com |
| Silence Therapeutics PLC | View profile | 109 | 72 Hammersmith Road, London, United Kingdom, W14 8TH | www.silence-therapeutics.com |
| Sarepta Therapeutics Inc | View profile | 1,314 | 215 First Street, Suite 415, Cambridge, MA, United States, 02142 | www.sarepta.com |
| Percheron Therapeutics Ltd | View profile | 8 | 14 Wallace Avenue, LEVEL 1, Toorak, VIC, Australia, 3142 | www.antisense.com.au |
Latin America Antisense And RNAi Therapeutics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Antisense And RNAi Therapeutics Market Outlook will help companies and investors design strategic landscapes.
Rna Interference was the largest segment with a revenue share of 75.16% in 2023.
Horizon Databook has segmented the Latin America antisense and rnai therapeutics market based on rna interference, antisense rna covering the revenue growth of each sub-segment from 2018 to 2030.
- Latin America Antisense And Rnai Therapeutics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- RNA Interference
- Antisense RNA
- Latin America Antisense And Rnai Therapeutics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Neurodegenerative Disorders
- Genetic Disorders
- Cardiometabolic & Renal Disorders
- Ocular
- Cancer
- Skin Diseases
- Infectious Diseases
- Latin America Antisense And Rnai Therapeutics Market Route of Administration Outlook (Revenue, USD Million , 2018-2030)
- Intravenous Injections
- Intrathecal Injections
- Subcutaneous Injections
- Other Delivery Methods
Reasons to subscribe to Antisense And RNAi Therapeutics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Antisense And RNAi Therapeutics Market Outlook databook
- Our clientele includes a mix of Antisense And RNAi Therapeutics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Antisense And RNAi Therapeutics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Antisense And RNAi Therapeutics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Latin America Antisense And Rnai Therapeutics Market, 2018-2030 (US$M)
Latin America antisense and rnai therapeutics market statistics, by technology, 2018-2030 (US$M)
